Financial results for the period ended Jun 30, 2026
As filed · Piramal Pharma Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
EarningsMajormateriality 77 out of 100
What happened
FactPiramal Pharma Ltd. announced the approval of its unaudited financial results (standalone and consolidated) for the quarter ended 30th June, 2026, during a board meeting held on 29th July, 2026. The company will publish these results in newspapers and they are also available on its website. The board meeting commenced at 5:30 pm and concluded at 8:30 pm.
Why it matters
CapitSignal interpretationReported results are the point at which prior management commitments become checkable against audited or reviewed numbers.
Watch next
Fact- Margin trend against the prior period
- Cash from operations against reported profit
- Whether prior guidance is reaffirmed
Evidence
How CapitSignal classified this
- Reasoning:
- RESULTS base 68; +4 corroborating keywords; +5 quantified amount; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 90%